CMB
Click for more information
11.4% 35.0¢ cambium bio limited

Ann: Positive clinical trial results for Progenza, page-12

  1. Biotechasx
    172 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    22/05/17
    13:35
    Post #: 24834750
    Orthocell (ASX:OCC) announced the start of Phase 2 trials in 2011... but this was never verified (http://ausbiotech2011.com.au/uploads/Orthocell.pdf)

    At this stage, the use of MSCs in Phase 2 trials seems to be only happening with RGS and MSB, indeed.
    RGS Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
35.0¢ 		Change
-0.045(11.4%) 		Mkt cap ! $4.175M
Open High Low Value Volume
39.0¢ 39.0¢ 35.0¢ $46 127

Buyers (Bids)

No. Vol. Price($)
1 75 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 1910 1
View Market Depth
Last trade - 13.58pm 09/08/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.